NEONATAL EXPOSURE TO AROCLOR-1254 - EFFECTS ON ADULT HEPATIC TESTOSTERONE HYDROXYLASE-ACTIVITIES

被引:17
作者
HAAKEMCMILLAN, JM [1 ]
SAFE, SH [1 ]
机构
[1] TEXAS A&M UNIV SYST,COLL VET MED,DEPT VET PHYSIOL & PHARMACOL,COLLEGE STN,TX 77843
关键词
D O I
10.3109/00498259109039488
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The effects of neonatal exposure to Aroclor 1254 (100-mu-mol/kg) on the metabolism of testosterone by adult male and female rats were determined by comparing their hepatic microsomal testosterone hydroxylase activities at 60, 90 and 120 days after the initial exposure. 2. The most pronounced effects in male rats were observed 90 days after treatment with Aroclor 1254, whereas in female rats the major changes in testosterone hydroxylase activities were observed after 60 days. 3. Ninety-day-old male rats neonatally treated with Aroclor 1254 exhibited decreased basal testosterone 7-alpha-hydroxylase and increased basal testosterone 16-alpha-, 2-alpha- and 15-beta-hydroxylase activities and androstenedione formation. In addition, the Aroclor 1254-mediated induction of testosterone 7-alpha- and 6-alpha-hydroxylase activities and androstenedione formation was decreased, and that of testosterone 2-beta- and 15-beta-hydroxylase activities was increased. 4. Sixty-day-old female rats exposed neonatally to Aroclor 1254 exhibited increased basal testosterone 16-alpha-, 2-beta-, 6-alpha- and 15-beta-hydroxylase activities and androstenedione formation, and increased Aroclor 1254-induced metabolism of testosterone at all positions except 16-alpha and 2-alpha. 5. Changes in testosterone hydroxylase activities indicative of permanent damage (or imprinting) in androgen metabolism, i.e. altered activities in 120-day-old animals, were observed only in male rats. These activities included basal testosterone 6-beta-, 16-alpha- and 2-alpha-hydroxylase activities and androstenedione formation.
引用
收藏
页码:481 / 489
页数:9
相关论文
共 19 条
[1]   XENOBIOTIC IMPRINTING OF THE HEPATIC MONOOXYGENASE SYSTEM - EFFECTS OF NEONATAL PHENOBARBITAL ADMINISTRATION [J].
BAGLEY, DM ;
HAYES, JR .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (07) :1007-1014
[2]  
CONNEY AH, 1965, ANN NY ACAD SCI, V123, P98
[3]   PURIFICATION AND CHARACTERIZATION OF MICROSOMAL CYTOCHROME-P-450S [J].
GUENGERICH, FP ;
DANNAN, GA ;
WRIGHT, ST ;
MARTIN, MV ;
KAMINSKY, LS .
XENOBIOTICA, 1982, 12 (11) :701-716
[4]   NEONATAL PHENOBARBITAL IMPRINTING OF RAT HEPATIC-MICROSOMAL TESTOSTERONE HYDROXYLATIONS [J].
HAAKE, JM ;
SAFE, SH .
JOURNAL OF BIOCHEMICAL TOXICOLOGY, 1988, 3 :309-319
[6]   MODULATION OF RAT HEPATIC-MICROSOMAL TESTOSTERONE HYDROXYLASES BY 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN AND RELATED TOXIC ISOSTEREOMERS [J].
KEYS, B ;
HLAVINKA, M ;
MASON, G ;
SAFE, S .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1985, 63 (12) :1537-1542
[7]   ALTERED IMPRINTING OF RAT-LIVER MONOAMINE-OXIDASE BY ORTHO,PARA'-DDT AND METHOXYCHLOR [J].
LAMARTINIERE, CA ;
LUTHER, MA ;
LUCIER, GW ;
ILLSLEY, NP .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (05) :647-651
[8]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[9]  
MATTHEWS HB, 1975, DRUG METAB DISPOS, V3, P371
[10]   THE P450 GENE SUPERFAMILY - RECOMMENDED NOMENCLATURE [J].
NEBERT, DW ;
ADESNIK, M ;
COON, MJ ;
ESTABROOK, RW ;
GONZALEZ, FJ ;
GUENGERICH, FP ;
GUNSALUS, IC ;
JOHNSON, EF ;
KEMPER, B ;
LEVIN, W ;
PHILLIPS, IR ;
SATO, R ;
WATERMAN, MR .
DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1987, 6 (01) :1-11